Clinical trial
Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse
NCT05211804 is registered in ClinicalTrials.gov with Sorlandet Hospital HF as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse
- Lead sponsor
- Sorlandet Hospital HF
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 8, 2022
- Completion date
- May 21, 2024
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.